Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis

OBJECTIVE: To identify subsets of chronic obstructive pulmonary disease (COPD) patients who are more protected from exacerbations with the use of an inhaled corticosteroid/long-acting β(2) agonist (ICS/LABA) combination, compared with the use of LABA monotherapy. DESIGN: Post hoc cluster analysis of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: DiSantostefano, Rachael L, Li, Hao, Rubin, David B, Stempel, David A
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2013
Matèries:
Respiratory Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3641457/
https://ncbi.nlm.nih.gov/pubmed/23613569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-001838
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars